rezatapopt
rezatapopt: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-label, 2-part, Drug-Drug Interaction Study to Evaluate the Effects of Multiple Oral Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
Frequently asked questions
Who is developing rezatapopt?
rezatapopt is being developed by PMV Pharmaceuticals, Inc..
How many clinical trials involve rezatapopt?
BioSniper tracks 1 clinical trial involving rezatapopt.
Get deeper analysis on rezatapopt
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis